AHR and inflammatory bowel disease: Additional investigations in the context of chronic inflammation like inflammatory bowel disease (IBD) have shown that hypoxia and HIF-1α impair UCB-induced CD39 upregulation in Th17 cells that become less responsive to AhR activation (Xie et al., 2018).